DK485282A - Anthraniloyloxyalkanoater - Google Patents

Anthraniloyloxyalkanoater Download PDF

Info

Publication number
DK485282A
DK485282A DK485282A DK485282A DK485282A DK 485282 A DK485282 A DK 485282A DK 485282 A DK485282 A DK 485282A DK 485282 A DK485282 A DK 485282A DK 485282 A DK485282 A DK 485282A
Authority
DK
Denmark
Prior art keywords
alkyl
phenethyl
phenyl
anthraniloyloxyalkanoates
benzoylethyl
Prior art date
Application number
DK485282A
Other languages
English (en)
Inventor
Dante Nardi
Gianni Motta
Rodolfo Testa
Gabriele Graziani
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of DK485282A publication Critical patent/DK485282A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Control Of Position, Course, Altitude, Or Attitude Of Moving Bodies (AREA)
  • Toys (AREA)
  • Radio Relay Systems (AREA)
  • Saccharide Compounds (AREA)
DK485282A 1981-11-14 1982-11-02 Anthraniloyloxyalkanoater DK485282A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134398 1981-11-14

Publications (1)

Publication Number Publication Date
DK485282A true DK485282A (da) 1983-05-15

Family

ID=10525904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK485282A DK485282A (da) 1981-11-14 1982-11-02 Anthraniloyloxyalkanoater

Country Status (19)

Country Link
US (1) US4482561A (da)
EP (1) EP0079740B1 (da)
JP (1) JPS58135882A (da)
AT (1) ATE16490T1 (da)
AU (1) AU9045382A (da)
CA (1) CA1193260A (da)
DE (1) DE3242196A1 (da)
DK (1) DK485282A (da)
ES (1) ES517062A0 (da)
FI (1) FI823723L (da)
GR (1) GR77367B (da)
HU (1) HU188224B (da)
IL (1) IL67194A (da)
IT (1) IT1196425B (da)
NL (1) NL8204384A (da)
NO (1) NO823659L (da)
NZ (1) NZ202320A (da)
PT (1) PT75834B (da)
ZA (1) ZA828234B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3742580C1 (de) * 1987-12-16 1989-05-11 Schaper & Bruemmer Gmbh Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL250478A (da) * 1959-04-15
FR6103M (da) * 1967-02-22 1968-06-10
FR6195M (da) * 1967-04-11 1968-07-22
FR2434808A1 (fr) * 1978-09-01 1980-03-28 Science Union & Cie Nouveaux esters du methyl-1 piperidinol-4, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2467846A1 (fr) * 1979-10-22 1981-04-30 Dufour J C Nouveaux b hydroxy esters de piperidyle

Also Published As

Publication number Publication date
PT75834A (en) 1982-12-01
FI823723A0 (fi) 1982-11-01
ATE16490T1 (de) 1985-11-15
HU188224B (en) 1986-03-28
IL67194A (en) 1986-04-29
IT8224204A1 (it) 1984-05-12
ES8404685A1 (es) 1984-05-16
EP0079740A1 (en) 1983-05-25
ZA828234B (en) 1983-09-28
FI823723A7 (fi) 1983-05-15
GR77367B (da) 1984-09-11
NO823659L (no) 1983-05-16
CA1193260A (en) 1985-09-10
IT1196425B (it) 1988-11-16
DE3242196A1 (de) 1983-05-26
FI823723L (fi) 1983-05-15
JPS58135882A (ja) 1983-08-12
IL67194A0 (en) 1983-03-31
NL8204384A (nl) 1983-06-01
IT8224204A0 (it) 1982-11-11
ES517062A0 (es) 1984-05-16
AU9045382A (en) 1983-05-19
US4482561A (en) 1984-11-13
NZ202320A (en) 1985-05-31
EP0079740B1 (en) 1985-11-13
PT75834B (en) 1985-11-12

Similar Documents

Publication Publication Date Title
BG104254A (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
FR2639636B1 (fr) Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
ES2031821T3 (es) Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo.
AR021355A1 (es) Derivados de quinolina. procedimiento para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de unmedicamento
DK188288A (da) 1-phenyl-3-naphthalenyloxypropanaminer, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske midler indeholdende disse
DK0464465T3 (da) Substituerede aminoalkylbiphenylderivater, antimykotiske præparater indeholdende disse derivater og mellemprodukter til fremstilling deraf
DK234388A (da) 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling
HUP0302157A2 (hu) 4-(2-Fenil-tiazol-5-il)-1,4-diazabiciklo[3.2.2]nonán-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
PT87073A (pt) 4-]4-]4-]4-]]2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl"methoxy"phenyl"-1-piperazinyl"phenyl"triazolones
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
SE8802412D0 (sv) Thiourea derivatives
DK0902684T3 (da) Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler
FR2632639B1 (fr) Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
DK0461958T3 (da) 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien
IT1196425B (it) Antraniloilossialcanoati
DK0648202T3 (da) Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler
DK163783D0 (da) Fremgangsmade til fremstilling af imidazolinderivater
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
DK158729C (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DK452088A (da) 4-amino-6,7-dimethoxy-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)quinolin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antiarytmiske laegemidler samt n-(1-oe1,2,3,4-tetrahydroisozuinolin-2-ylaaethyliden)-2-cyan-4,5-dimethoxyanilin-forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
DK356287A (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
BR9902841A (pt) Compostos de 8h-tieno-{2,3-b}pirrolizin-8-ona, processo para suas preparações e composições farmacêuticas contendo os mesmos
ATE26275T1 (de) Acridanon-derivate.
ES8606355A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment